Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Apr
28
2023
Moving Towards MOCRA Implementation: FDA Announces Industry “Listening Session” Mintz
Apr
28
2023
MCDERMOTTPLUS CHECK-UP: APRIL 28, 2023 McDermott Will & Emery
Apr
28
2023
FTC Puts Almost 700 Advertisers on Notice That They May Face Civil Penalties for Unsubstantiated Claims ArentFox Schiff LLP
Apr
27
2023
Council of the EU Approves Conclusions on the Opportunities of the Bioeconomy Bergeson & Campbell, P.C.
Apr
27
2023
Breaking Up Is Hard to Do: Validity Upheld Based on Expert Separation Testimony McDermott Will & Emery
Apr
27
2023
Digitalization of Procedures for Cosmetic Products OLIVARES
Apr
27
2023
USDA Proposes Declaring Salmonella an Adulterant in Breaded Stuffed Raw Chicken Products Keller and Heckman LLP
Apr
26
2023
Withdrawal of Drug Approval Highlights Risk of Accelerated Approval Pathway Sheppard, Mullin, Richter & Hampton LLP
Apr
26
2023
The Legal Battle Over Mifepristone Epstein Becker & Green, P.C.
Apr
26
2023
FDA Announces Public Meeting on Good Manufacturing Practices for Cosmetic Products Keller and Heckman LLP
Apr
25
2023
China Publishes Long-awaited Management Measures for the Supervision of Toothpaste Keller and Heckman LLP
Apr
25
2023
FDA to Reopen Comment Period for Guidance on Labeling of Plant-based Milk Alternatives Keller and Heckman LLP
Apr
24
2023
On the Horizon: Broad Employment Protections for Marijuana Users in the District of Columbia Sheppard, Mullin, Richter & Hampton LLP
Apr
24
2023
GAO Science and Tech Spotlight Describes Benefits of Synthetic Biology and Challenges Ahead Bergeson & Campbell, P.C.
Apr
24
2023
FDA Issues Request for Information on Food Labeling in Online Grocery Shopping Keller and Heckman LLP
Apr
24
2023
Understanding Recent Litigation on Medication Abortion: A Guide for Health Plan Sponsors Proskauer Rose LLP
Apr
24
2023
A UK Perspective on Dealing with Alcohol Dependence in the Workplace Vedder Price
Apr
24
2023
Delaware Legalizes Recreational Marijuana Jackson Lewis P.C.
Apr
22
2023
France Extends Due Date for R-Nano Declarations to May 31, 2023 Bergeson & Campbell, P.C.
Apr
20
2023
Cannabis Day: Top 10 Weed Roundup of Budding Trends’ Trendiest Blog Posts of the Year (Obligatory 420 Post) Bradley Arant Boult Cummings LLP
Apr
20
2023
FAO and WHO Issue Publication on Food-Safety Aspects of Cell-Based Food Bergeson & Campbell, P.C.
Apr
20
2023
Nevada Proposes to Add a Whistleblower Provision to Existing Cannabis Law Mintz
Apr
20
2023
Do Mississippi’s Medical Cannabis Advertising and Marketing Restrictions Go Too Far? Bradley Arant Boult Cummings LLP
Apr
20
2023
U.S. Supreme Court Declines to Hear Acrylamide Case Keller and Heckman LLP
Apr
20
2023
Searching for Claim Support in a Patent Specification? You Better Blaze a Trail Bradley Arant Boult Cummings LLP
Apr
20
2023
What Cannabis Industry Employers Need to Know About Cal/OSHA Jackson Lewis P.C.
Apr
19
2023
FAO-WHO Issues First Global Report on the Food Safety of Cell-Based Food Technology Keller and Heckman LLP
Apr
19
2023
Cofepris Will Investigate the 63 Cannabis Permits Granted in Mexico Back on 2018 OLIVARES
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins